Based in the United States, Tune Therapeutics is a startup.
Tune Therapeutics develops next-generation cell and gene therapies using targeted epigenetic modifiers to regulate gene expression without altering DNA sequences.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.